NCT07312786Recruiting
Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors
Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors After Completing Primary Treatment
Source: ClinicalTrials.gov · Last updated 14 May 2026
Brief summary (registry, in English)
The goal of this study is to determine the feasibility of implementing a mobile health application for breast and colorectal cancer survivors following primary treatment. Developed in collaboration with Seamless MD, the intervention acts as an information hub, providing users with timely and evidence-based information related to follow-up care as well as health system/community-based resources and programs to meet their needs during this period of care. The goal of the intervention is to encourage open communication regarding survivorship expectations and provide survivors with appropriate information and support to meet their needs. This study will: 1. Test the feasibility of implementing the virtual intervention at two cancer centres in Atlantic Canada (Nova Scotia and New Brunswick) 2. Gather feedback regarding the intervention from cancer survivors and healthcare providers. Participants will have access to the intervention for a period of six months. Questionnaires will be distributed to participants through the intervention at baseline, 90 days, and 180 days to assess user experience. Semi-structured interviews will be conducted with select survivor participants and healthcare providers (oncology and primary care) to determine the feasibility and acceptability of this intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 24 Nov 2025
- Start date
- 20 Apr 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Nova Scotia Health Authority
- Diseases
- Colorectal cancer
- NCT number
- NCT07312786
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 20 Apr 2026 to the primary completion date, 31 Dec 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Adults older than 18 years, capable of providing informed consent
- Diagnosed with stage I-III breast or colorectal cancer, and have completed primary treatment for their cancer (surgery and/or adjuvant systemic or radiation therapy) 6 months - 5 years ago
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Clinical Research QEII Health Sciences Centre Coordinator of this site? Confirm its status | Halifax | Canada | Recruiting |
| Saint John Regional Hospital Coordinator of this site? Confirm its status | Saint John | Canada | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.